Dr Michael Baker interviewed on ‘The Sub11 Podcast’

CEO and Managing Director, Dr Michael Baker, recently chatted with host Chris Titley for The Sub11 Podcast’s ‘Uncovered’ series.

The conversation offered an in-depth look into the work being done at Arovella. Dr Baker expressed optimism about the future, pointing out that Arovella's scalable approach to cell therapy has the potential to increase access to life-saving treatments for patients worldwide.

Listen to the podcast: Michael Baker - Arovella Therapeutics - Sub11 Uncovered: Amplifying Innovation